Managers / Q2 2023 · view latest →
ALGERT GLOBAL LLC
CIK 0001275218 · 101 CALIFORNIA STREET, SUITE 3240, SAN FRANCISCO, CA, 94111 · 415-675-7300
Summary
Algert Global LLC reported $2.3B in U.S.-listed holdings across 1,067 positions for Q2 2023.
Compared with Q1 2023, the fund opened 219 new positions and exited 269.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 91.4% · $2.1B
- REIT · 5.4% · $124M
- Other · 3.2% · $73M
- ADR · 0.0% · $214,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| UFPIUFP INDUSTRIES INC | NEW | +120.4K | 120.4K | +$12M | $12M |
| SYNASYNAPTICS INC | NEW | +88.7K | 88.7K | +$8M | $8M |
| TOLTOLL BROTHERS INC | NEW | +82.3K | 82.3K | +$7M | $7M |
| NCLHNORWEGIAN CRUISE LINE HLDG L | NEW | +284.3K | 284.3K | +$6M | $6M |
| OVVOVINTIV INC | NEW | +155.8K | 155.8K | +$6M | $6M |
| CELHCELSIUS HLDGS INC | NEW | +38.8K | 38.8K | +$6M | $6M |
| INTRA-CELLULAR THERAPIES INC | NEW | +89.5K | 89.5K | +$6M | $6M |
| CRCRANE COMPANY | NEW | +61.2K | 61.2K | +$5M | $5M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $6.6B | 1,134 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $6.4B | 1,120 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $6.0B | 1,113 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $4.8B | 1,167 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $4.0B | 1,160 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $4.2B | 1,153 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $3.7B | 1,152 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $3.0B | 1,482 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.6B | 1,052 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $2.5B | 1,111 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.1B | 1,085 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.3B | 1,067 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $2.1B | 1,117 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.8B | 1,117 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.7B | 1,154 | Nov 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.3B | 1,176 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.5B | 1,164 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $801M | 947 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $751M | 1,008 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $297M | 416 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $313M | 427 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $351M | 400 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $315M | 393 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $295M | 411 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $237M | 402 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $335M | 371 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $268M | 355 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $271M | 341 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $175M | 298 | May 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $359M | 367 | Feb 1, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- North Square Investments, LLC028-129569
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.